Good news: fund available for 2nd study, case by case study on all results, working closely with hospitals
bad news: no timeline but hope to set dates end of this month
also revise algo, improvements identified, over 1200 sets which will improve data, same group of hospitals for pediatric trial
Australian adult studies in parallel, 8.5 million cash in bank for all trials
- Forums
- ASX - By Stock
- RAP
- Conference Call Summary
Conference Call Summary, page-9
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 568 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost